BIIB Jul 2024 227.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3500

-7.6500

(-85.00%)

As of 09:56AM EDT. Market open.

Loading interactive chart…

Investor's Business Daily
Biden Just Knocked Eli Lilly Stock Off Its Pedestal — Is It A Buy Or A Sell?
Is Eli Lilly stock a buy or a sell after Joe Biden called out Lilly and Novo Nordisk for high drug prices? Is LLY stock a buy or a sell?
Investor's Business Daily
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
Insider Monkey
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
ClearBridge Investments, an investment management company, released its “ClearBridge Value Equity Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The strategy outperformed the Russell 1000 Value Index in the first quarter. On an absolute basis, the strategy has gained 9 out of eleven sectors it invested in during […]